{
    "Trade/Device Name(s)": [
        "CareSens N Voice Blood Glucose Monitoring System",
        "CareSens N Single Blood Glucose Test Strips",
        "CareSens Control Solutions"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K121133",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083468"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "June 12, 2012",
    "Summary Letter Received Date": "June 14, 2012",
    "Submission Date": "April 09, 2012",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CareSens N Voice Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method",
        "Electro-chemical reaction",
        "Glucose oxidase (Aspergillus sp.)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for CareSens N Voice Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood, intended for self-testing by people with diabetes.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips and alternative sites for self-testing by people with diabetes at home; not for neonatal use or diabetes diagnosis/screening.",
    "fda_folder": "Clinical Chemistry"
}